- Home
- LECO vs RGC Comparison
LECO vs RGC Comparison
Compare LECO & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LECO | RGC |
|---|---|---|
| Founded | 1895 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.4B | 13.2B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | LECO | RGC |
|---|---|---|
| Price | $287.42 | $31.50 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $272.78 | N/A |
| AVG Volume (30 Days) | ★ 503.8K | 356.2K |
| Earning Date | 02-12-2026 | 10-31-2025 |
| Dividend Yield | ★ 1.08% | N/A |
| EPS Growth | ★ 14.36 | N/A |
| EPS | ★ 9.32 | N/A |
| Revenue | ★ $4,233,002,999.00 | N/A |
| Revenue This Year | $9.02 | N/A |
| Revenue Next Year | $5.05 | N/A |
| P/E Ratio | $31.51 | ★ N/A |
| Revenue Growth | ★ 5.60 | N/A |
| 52 Week Low | $161.11 | $0.09 |
| 52 Week High | $310.00 | $83.60 |
Technical Indicators
Market Signals| Indicator | LECO | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 62.11 | 54.41 |
| Support Level | $271.00 | $25.80 |
| Resistance Level | $310.00 | $35.70 |
| Average True Range (ATR) | 10.60 | 3.54 |
| MACD | 0.91 | 0.05 |
| Stochastic Oscillator | 60.59 | 59.17 |
Price Performance
Historical ComparisonAbout LECO Lincoln Electric Holdings Inc.
Lincoln Electric is a leading manufacturer of welding, cutting, and brazing products. Its portfolio includes arc-welding solutions, plasma and oxy-fuel cutting systems, brazing and soldering alloys, and automation solutions. Lincoln Electric serves clients across general fabrication, heavy industries, automotive, construction, shipbuilding, energy, and process industries, among others. Based in Cleveland, Lincoln Electric operates in 19 countries and employs 11,000 worldwide. The company generated roughly $4 billion in sales in 2024.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.